Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
Abstract Background Polycystic ovary syndrome (PCOS) is a multifactorial endocrinopathy that affects reproduction and metabolism. Mammalian target of rapamycin (mTOR) has been shown to participate in female reproduction under physiological and pathological conditions. This study aimed to investigate...
Saved in:
Main Authors: | Zaixin Guo (Author), Xiaohan Chen (Author), Penghui Feng (Author), Qi Yu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Testosterone and dehydroepiandrosterone sulfate serum levels and anthropometric indices among patients with polycystic ovary syndrome taking metformin and cyproterone compound
by: Mina Mohseni Shooshtari, et al.
Published: (2023) -
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats
by: Gengxiang Wu, et al.
Published: (2020) -
Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats
by: Fuzhen Zhao, et al.
Published: (2024) -
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes
by: Haowen Wu, et al.
Published: (2023) -
Polycystic Ovary Induction in Mouse by Testosterone Enanthate
by: Zahra Kalhori, et al.
Published: (2013)